hotspot -WSS

hotspot

author：entertainment 2025-09-30 22:55:11 - browse：6

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

The Food and Drug Administration on Thursday approved an Eli Lilly drug that takes a new approach to treating ulcerative colitis, a chronic inflammatory disease that can cause intense gastrointestinal pain and distress.

The therapy, dubbed Omvoh, is an antibody that blocks IL-23p19, an immune signaling molecule that plays a key role in sustaining the disease. It’s the first treatment to target this particular pathway in ulcerative colitis. The drug’s approval comes after two late-stage trials found that patients taking Omvoh showed a significant improvement in symptoms after both three months and a year compared with those given a placebo, and that the therapy had minimal side effects.

Omvoh’s list price will be $9,593 per month for intravenous delivery and $10,360 per dose injected beneath the skin. A company spokesperson told STAT that patients who have the drug covered by commercial insurance may pay as little as $5 per month for up to 30 months.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Nearly two

WSS

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

Mike Pence clashes with Tucker Carlson in Iowa

Involuntary treatment for addiction doesn't work

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

Blood tests recalled over risk of missed heart attack diagnosis

hotspot

hotspot

Wikipedia

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

Bright Health sells Medicare Advantage business to Molina

Biden calls for immediate release of Niger's president amid apparent coup

Medicare proposal to cover medical devices draws a mixed reaction

TytoCare raises $49 million to build out AI

Continuity nursing helped my family in our darkest PICU moments

TytoCare raises $49 million to build out AI

The high cost of giving birth even with insurance

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

focus

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

Argenx drug significantly slows progression of nerve disorder

Mike Pence clashes with Tucker Carlson in Iowa

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

Federal judge rules Oregon’s tough new gun law is constitutional

hotspot

hotspot

focus

explore